FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Waives Efficacy Studies for Stelara Biosimilar

FDA agrees to accept a biosimilar application to compete with Johnson & Johnsons Stelara that does not include clinical efficacy studies for a monoclo...

Medical Devices

Medtronic Gets FDA Green Light for Diabetes Devices

FDA clears a Medtronic 510(k) for its MiniMed 780G insulin delivery system to integrate with Abbotts Instinct continuous glucose monitoring sensor for...

Biologics

FDA Vaccines Panel Member Offit Removed

HHS says FDA is removing members of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) and Childrens Hospital of Philadelphias V...

latest-news-card-1
Human Drugs

J&J Kills Nipocalimab Plus Tumor Necrosis Factor in RA

Johnson & Johnson decides to stop development of nipocalimab in combination with an anti-tumor necrosis factor alpha therapy for rheumatoid arthritis ...

latest-news-card-1
Human Drugs

Novocure Scraps TTFields Study for Real-World Data

Novocure stops its LUNAR-4 study, a Phase 2 open-label trial testing Tumor Treating Fields together with Mercks Keytruda (pembrolizumab) in lung cance...

latest-news-card-1
Medical Devices

Medtronic Wins Expanded Use for Evolut Aortic Valve

FDA approves an expanded use for Medtronics Evolut transcatheter aortic valve replacement system, allowing implantation of a new Evolut valve inside a...

latest-news-card-1
Medical Devices

Ambu Recalls its SPUR II Resuscitators

Ambu recalls (Class 1) its SPUR II resuscitators due to the manometer port being blocked, which causes the manometer to become non-functional.

latest-news-card-1
Medical Devices

Hamilton Recalls Defective Coaxial Breathing Sets

Hamilton Medical recalls (Class 1) certain lots of coaxial breathing sets due to a quality issue involving a defective blade in the tube-cutting stage...

latest-news-card-1
Biologics

Alzheimers Therapy Gets At-Home Injection Approval

FDA approves an Eisai/Biogen at-home injection option for Alzheimers treatment Leqembi (lecanemab), expanding access to patients in the early stages o...

latest-news-card-1
Human Drugs

Foresee Pharmas 3-Month Camcevi Formulation OKd

FDA approves a Foresee Pharmaceuticals NDA for Camcevi ETM (leuprolide mesylate), a once every three-month injectable formulation for treating advance...